Experts, Greentown family weigh in on hemophilia

Experts, Greentown family weigh in on hemophilia

If you look closely, you’ll see him underneath the Friday night lights during varsity football season at Eastern High School.

Takeda to discontinue Hemofil M, Recombinate for hemophilia A

Takeda Pharmaceuticals has decided to discontinue Hemofil M (human antihemophilic factor) and Recombinate (recombinant antihemophilic factor), both of which are approved as replacement therapies to prevent and control bleeding episodes in children and adults with hemophilia A. “This was not a decision we made lightly,” Anthea Cherednichenko, Takeda’s vice president and franchise head of U.S. hematology, wrote in a letter informing patients of th…